Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

17.08
+0.47502.86%
Volume:3K
Turnover:44.61K
Market Cap:634.23M
PE:-2.30
High:17.15
Open:16.43
Low:16.43
Close:16.60
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.55
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.74
PE(LYR):-1.33

Loading ...

Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 02, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 27, 2022

Major Issues Report

8-K - Current report
Dec 27, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership